Susquehanna Fundamental Investments LLC Buys New Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Susquehanna Fundamental Investments LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 267,222 shares of the company's stock, valued at approximately $20,891,000. Susquehanna Fundamental Investments LLC owned 0.06% of GE HealthCare Technologies at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in GEHC. Capital Research Global Investors lifted its holdings in GE HealthCare Technologies by 4.5% during the fourth quarter. Capital Research Global Investors now owns 60,832,004 shares of the company's stock worth $4,755,851,000 after buying an additional 2,608,066 shares during the period. Vanguard Group Inc. lifted its stake in shares of GE HealthCare Technologies by 4.3% during the 4th quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock worth $4,107,378,000 after purchasing an additional 2,155,429 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of GE HealthCare Technologies by 3.1% during the 4th quarter. Geode Capital Management LLC now owns 11,320,576 shares of the company's stock worth $882,777,000 after purchasing an additional 342,819 shares during the last quarter. Invesco Ltd. boosted its position in GE HealthCare Technologies by 18.4% during the fourth quarter. Invesco Ltd. now owns 8,067,927 shares of the company's stock valued at $630,751,000 after purchasing an additional 1,252,613 shares in the last quarter. Finally, Norges Bank purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $488,531,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded up $0.02 during trading hours on Tuesday, reaching $68.09. The stock had a trading volume of 5,687,469 shares, compared to its average volume of 3,272,290. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a market cap of $31.17 billion, a P/E ratio of 15.73, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The stock has a fifty day moving average of $76.10 and a 200 day moving average of $81.91.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.21%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Piper Sandler lowered their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Citigroup upped their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $96.50.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.